• About us
  • Privacy Policy
  • Contact us
Neo Science Hub
ADVERTISEMENT
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
        • Dr. G. V. Purnachand
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In
No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
        • Dr. G. V. Purnachand
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In
No Result
View All Result
Neo Science Hub
No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In

Research indicates that over 30% of Covaxin users reported Menstruation Irregularities and Neurological System Issues

Raja Aditya by Raja Aditya
3 years ago
in Healthcare & Medicine, Science News
0
Covaxin

Research indicates that over 30% of Covaxin users reported Menstruation Irregularities and Neurological System Issues | Neo Science Hub

Approximately thirty percent of the 926 recipients of Bharat Biotech’s Covaxin suffered adverse events of special interest (AESI), according to a recent study by experts at Banaras Hindu University (BHU).

One percent of participants had Guillain-Barre syndrome, which causes weakness in the arms and legs due to nerve damage, and stroke, according to the adverse events recorded by the recipients.

The adult participants had a range of problems, such as nervous system illnesses, musculoskeletal disorders, and general disorders.                      

Skin and subcutaneous problems, general disorders, and nervous system illnesses were the most common AESIs among teenagers. Furthermore, the study found that about 4.6% of women had irregular menstruation.

According to the study, around one-third of the participants had AESIs. The three most frequent conditions seen in teenagers following vaccination were general diseases, nervous system disorders, and new-onset skin and subcutaneous illnesses.”

According to the research, four adult deaths—three of them female and one of them male—were documented, as PTI reported. It said that all four had diabetes, three had hypertension, and two had a history of COVID-19 prior to immunization.

“Adults receiving three doses and those receiving one dose of BBV152 were respectively at four and two times higher risk of AESIs compared with adults receiving two doses of the Covaxin,” according to the research.

The research was carried out between January 2022 and August 2023. According to the study, around half of the sample size reported having an infection, with viral upper respiratory tract infections being the most prevalent kind.

When contacted for comment, Bharat Biotech stated that company has an outstanding safety record and that several studies on the safety of Covaxin have been conducted and published in peer-reviewed publications. It also listed a number of prerequisites for this kind of research, one of which was an evaluation of the participants’ AESI profiles.

It further said that over the course of the investigation, the safety profiles of the unvaccinated participants should be compared. The Covaxin research was conducted just a few days after AstraZeneca pulled the Covid-19 vaccine, which was sold as “Covishield” in India, due to unusual adverse effects such blood clotting.

-Raja Aditya

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Share on Tumblr (Opens in new window) Tumblr
  • Share on Telegram (Opens in new window) Telegram
  • Email a link to a friend (Opens in new window) Email
Tags: adverse events of special interest (AESI)AstraZenecaBanaras Hindu University (BHU)CovaxinCOVID-19 vaccineCovishieldfeaturedgeneral disordersGuillain-Barre syndromemusculoskeletal disordersnervous system illnessessciencenews
Raja Aditya

Raja Aditya

Associate Editor for Neo Science Hub Magazine

Other Posts

Young maize in paired rows on raised beds with water in the furrows between them

Lifting the Crop Off the Floor: Why Raised Beds Are Gaining Ground in a Water-Short Country

November 15, 2026 - Updated on November 16, 2026
3
Trays of green and purple microgreens beside a field being sprayed

Small Leaves, Small Particles: Microgreens Have the Evidence. Nano-Urea Is Still Earning It

November 15, 2026 - Updated on November 16, 2026
4

A Crore and a Half Recharge Pits Later: What India’s Water Reforms Can, and Cannot, Teach the Global South

A Purple Broccoli That Seeds in Delhi and a Sponge Gourd That Shrugs Off a Virus

Fourteen Seconds to 241 km/h and Back: What a Runway Test Says About Where Car Performance Now Lives

An Aeroplane on a Helipad: What Electra’s Manhattan Landing Proves, and What It Does Not

After the Space Station: NASA Opens the Contest to Become a Tenant in Orbit

At 94, the Air Force Counts Its Squadrons, and Waits for an Engine India Can Call Its Own

Next Post
Google Cloud

Google Cloud launches AI-driven security operations in India

Please login to join discussion

Subscribe to Us

Latest Articles

Cross-section of a human eye with the optic nerve head highlighted

FDA Orders Eye-Risk Warnings on All GLP-1 Drugs, From Ozempic to Mounjaro

November 12, 2026
8

Delhi’s Diwali, Measured: Firecrackers Drove 71% of Fine Particles, Lead Hit 20 Times the Limit, and the Worst Readings Went Missing

Global Carbon Budget 2026: The World’s Fossil Emissions Dip, India’s Rise 4.4%, and the 1.5 °C Budget Is Nearly Spent

A New Kind of Blood Thinner: FDA Approves Asundexian to Prevent Repeat Strokes

Andhra Pradesh Opens the Door to Small Nuclear Reactors, Robots and Giga-Scale AI Data Centres — With the Details Still to Come

“Off the Charts”: WMO Tells COP31 That 2026 Is Among the Hottest Years on Record as a Record El Niño Builds

  • Advertise
  • Terms and Conditions
  • Privacy Policy
  • Refund Policy
  • Contact
For Feedback : Email Us

Copyrights © 2025 Neo Science Hub

No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In

Copyrights © 2025 Neo Science Hub

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist